Company Analysis
Sign in

Beta Bionics, Inc. (BBNX)

Nasdaq: BBNX · Surgical & Medical Instruments & Apparatus · Irvine, CA · filing with the SEC since 2016
Full chart Alerts Compare
Grade6.1
◀ Past 6.3● Present 6.1▶ Future 6.0
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenue$100M+53.9%
Net income-$73.2M-33.7%
Earnings per share$-1.81+79.0%
Operating cash flow-$50.9M-5.5%
Cash$31.7M+3.7%
Debtn/a
Shareholders’ equity$288M+217.2%
Shares, diluted40.5M+536.7%
Return on equity-25.4%
The recordfrom its filings
Filings in 2026129
Newest filingNov 12 · 4
Annual reportFeb 24, 2026
Quarterly reportOct 27, 2026
Next report due10-K by Mar 31
Insider sales, 12 months$5.4M
Insider buys, 12 months$0.00
Patents granted54
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Trailing twelve months to Sep 2026Revenue $127MNet income -$83.1MCash from operations -$59.4Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
232425
As filed, in USD. Nothing here is a forecast.

News

Nov 12, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 9, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 4, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 29, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 28, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 27, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton BBNX · research, not advice